Polaris Peptides Reviews 2026: Testing

Polaris Peptides is a research chemical supplier that sells lyophilized (freeze-dried) peptides, topical compounds, and synthesis precursors. The company explicitly states it is "not a compounding pharmacy or chemical compounding facility as defined under 503A." All products carry a "For Laboratory Research Use Only" label.

The company operates on a members-only model. Registration requires a company or institution name and business type. This gating mechanism is standard among research peptide vendors and serves as a legal buffer, establishing that purchases are for research rather than personal use.

Polaris operates under the legal entity Polaris Bioactives, LLC and runs two domains: polarispeptides.com (main site) and polarispeptidesusa.com (product catalog). The relationship between the two domains is not publicly explained. Domain WHOIS data is hidden behind Contact Privacy Inc. in Toronto, Canada. The company's ownership is not publicly disclosed.

The supplier gained significant visibility in early 2026 after Peptide Sciences shut down, sending researchers looking for alternatives. Monthly search volume for "polaris peptides" jumped to 12,000, reflecting this migration.

Finnrick Analytics, an independent peptide testing laboratory, has tested 97 samples across 9 Polaris Peptides products. The results show significant variation by product.

Three findings stand out from this data.

First, tirzepatide is the strongest product. The A grade across 15 samples with an 8.8 average and a floor of 6.5 indicates consistent quality. If you are sourcing tirzepatide for research, Polaris is a reliable option based on independent data.

Second, semaglutide scored a C despite being a flagship product. The 4.7 to 8.7 score range indicates batch variability. Some batches test well; others fall below acceptable thresholds.

Third, retatrutide earned a D with the widest score range of any product (3.9 to 9.0 across 26 samples). The 3.9 floor is concerning. Despite a 7.3 average, the inconsistency means any individual purchase carries meaningful quality risk. See our complete retatrutide guide for information about this investigational compound.

Polaris Peptides prices are competitive with the research peptide market. Here are key products.

These prices are competitive. Semaglutide 5mg at $50 and BPC-157 5mg at $25 are in line with or below market averages. The tirzepatide pricing at $240 for 30mg is standard for the research market. For context on reconstituting and calculating doses for research, use our reconstitution calculator and unit converter.

Available discount codes (as of March 2026):

Discount codes rotate seasonally. Verify codes at checkout before completing your order. The crypto discount stacks with coupon codes, making it the most cost-effective payment method. Free shipping applies to all orders over $350.

Polaris Peptides is a young company with limited but generally positive trust signals and some notable gaps.

User feedback across Trustpilot, Reddit, and peptide community forums shows a consistent pattern.

Swiss Chems holds a significant edge in transparency (COAs on product pages, longer track record, public ownership). Polaris gained volume after Peptide Sciences closed, but it has not yet established the same level of trust that Peptide Sciences had built over a decade.

A note on Swiss Chems COAs: While Swiss Chems displays COAs on product pages (a transparency advantage), community reports indicate that some Swiss Chems COAs lack lab names or verifiable contact information. Some users have also noted that certain COAs appear to repeat across different batches. This does not invalidate the COAs, but it suggests that "COA on product page" alone is not a complete trust signal. Verifying the testing laboratory independently remains the gold standard for both vendors.

For a comprehensive comparison of all available vendors, see our where to buy peptides 2026 guide and our analysis of Peptide Sciences alternatives.

Based on Finnrick Analytics independent testing data:

For peptides rated C or D, requesting and reviewing the batch-specific COA before purchase is strongly recommended.

The regulatory landscape for research peptides shifted significantly in 2025 and 2026. Understanding the current legal environment is essential before purchasing from any grey market vendor, including Polaris Peptides.

FDA enforcement has increased. The FDA escalated enforcement actions against research peptide vendors throughout 2025. Warning letters, seizures, and website shutdowns have become more common. The Peptide Sciences shutdown was the most visible example, but smaller vendors have also been affected. See our FDA peptide crackdown analysis for the full timeline.

The SAFE Drugs Act changed the legal framework. This legislation gave the FDA broader authority to regulate compounds sold as "research chemicals" when evidence suggests consumer use. Grey market vendors operating under the "for research use only" disclaimer face greater legal exposure than they did before 2025.

RFK peptide reclassification is reshaping access. Under the current administration, 14 of the 19 peptides previously categorized as Category 2 (restricted from compounding) are moving back to Category 1. Category 1 peptides can be compounded by licensed pharmacies with a valid prescription. This includes several peptides commonly purchased through grey market vendors.

This reclassification means that legal access routes are expanding. Telehealth platforms that connect patients with licensed prescribers, combined with compounding pharmacies, now offer a regulated path to many of the same peptides sold on grey market sites. The legal route provides pharmaceutical-grade quality, dosing guidance, and medical oversight.

Why this matters for Polaris customers. Purchasing from grey market vendors carries legal risk for both the vendor and the buyer. While Polaris Peptides operates under a "research use only" disclaimer, the FDA has signaled that this distinction is not a reliable legal shield. Researchers should understand the legal landscape before purchasing. For a complete breakdown of peptide legality, see our guide on whether peptides are legal.